Green Cross Health Ltd · NZX:GXH
Green Cross Health — H1 FY2021 Earnings Presentation
19 slides from Green Cross Health's earnings presentation, Nov 25, 2020
Slide 1: Half Year Results Presentation
Half Year Results Presentation 25 November 2020 GXH Half Year Results Presentation 25 November 2020 PgPg 1 1
Slide 2: GXH Half Year Result - Financial Overview
GXH Half Year Result - Financial Overview Revenue Pharmacy Operating Profit $277.2m¹ $10.9m Operating Profit /EBIT Medical Operating Profit 2 $17.9m $5.7m Net Profit After Tax Community Health $8.8m Operating Profit (attributable to shareholders) $2.4m Note: 1 Revenue includes $8.0m of government wa
Slide 3: Our Purpose
Our Purpose Working together to support healthier communities. We are passionately committed to the health and wellness of New Zealand, and to providing the best support, care and advice to our communities. This is our promise. GXH Half Year Results Presentation 25 November 2020 Pg 3
Slide 4: Who We Are
Who We Are GXH Half Year Results Presentation 25 November 2020 Pg 4
Slide 5: Pharmacy Division
Pharmacy Division New Zealand’s largest network of health retailers: supporting easy access to quality health care GXH Half Year Results Presentation 25 November 2020 Pg 5
Slide 6: Pharmacy Performance
Pharmacy Performance Pharmacy Operating Revenue Pharmacy Operating Profit $m $m 175 166 170 16 162 14.5 154 13.9 150 12.2 12 10.9 125 100 8 75 50 4 25 0 0 1H18 1H19 1H20 1H21 1H18 1H19 1H20 1H21 IFRS 16 Adjustment • Revenue down 5% at $153.7m, with mall stores and Auckland and Wellington CBD stores
Slide 7: Pharmacy Future Focus
Pharmacy Future Focus Retail Disciplines • Evolve retail offering to changing consumer behaviour post COVID-19 • Focus on margin management and core retail disciplines • Development of further professional service offers Customer Engagement • Strengthen digital capability around 1.7m Living Rewards
Slide 8: Medical Division
Medical Division Growth, leadership and sustainable models of care GXH Half Year Results Presentation 25 November 2020 Pg 8
Slide 9: Medical Performance
Medical Performance Medical Operating Revenue Medical Operating Profit $m $m 50 6 5.7 41 38 5 40 34 4 3.8 30 25 3 2.0 20 1.5 2 10 1 0 0 1H18 1H19 1H20 1H21 1H18 1H19 1H20 1H21 IFRS 16 adjustment • Revenue up 8% to $41.0m, primarily as a result of organic growth and some COVID-19 related swabbing act
Slide 10: Medical Future Focus
Medical Future Focus Network Scale • Continue to build The Doctors brand • Network and patient number growth through targeted acquisitions and organic revenue growth Patient Engagement • Scale digital technology to increase efficiency and enhance delivery of high quality patient care • Work closely
Slide 11: Community Health Division
Community Health Division Delivering sustainable services to maintain and support clients’ independence within their own home GXH Half Year Results Presentation 25 November 2020 Pg 11
Slide 12: Community Health Performance
Community Health Performance Community Health Operating Revenue Community Health Operating Profit $m $m 100 3.0 82 2.4 78 75 2.5 80 68 2.0 60 1.5 1.3 1.1 40 1.0 0.5 20 -0.1 0.0 1H18 1H19 1H20 1H21 0 -0.5 1H18 1H19 1H20 1H21 IFRS 16 adjustment • Revenue up 10% to $82.5m following ongoing focus on hig
Slide 13: Community Health Future Focus
Community Health Future Focus Service Offering • Focus on higher clinical needs segments • Expand geographic coverage of Community Nursing business Digital Communication • Harness technology to enhance workforce efficiency and client outcomes Financial Returns • Continue cost reduction initiatives •
Slide 14: Group Financial Result
Group Financial Result 6 months ending 30 September 2020 GXH Half Year Results Presentation 25 November 2020 Pg 14
Slide 15: Half Year Result - Group Revenue and Profit
Half Year Result - Group Revenue and Profit GXH Operating Revenue GXH Operating Profit $m $m 300 20 17.9 282 277 275 259 16.5 16.0 14.9 250 15 200 10 150 5 100 0 1H18 1H19 1H20 1H21 1H18 1H19 1H20 1H21 IFRS 16 Adjustment • Revenue flat at $277m year on year, including a government wage subsidy of $8
Slide 16: Net Profit After Tax (attributable to shareholders)
Net Profit After Tax (attributable to shareholders) GXH Net Profit after Tax Attributable to Shareholders $m 10.0 8.8 8.1 8.8 7.0 5.0 0.0 1H18 1H19 1H20 1H21 IFRS 16 Adjustment • NPAT attributable to shareholders of $8.8m, including an IFRS16 impact of -$0.2m and government wage subsidy of $4.6m (af
Slide 17: Operating Cash / Investments
Operating Cash / Investments GXH Operating Cash Flow $m 45 • Operating Cash of $39.1m ($29.4m before the 39.1 40 application of IFRS 16) 35 • Focus during the period on cash preservation given the uncertainty caused by the COVID-19 30 pandemic – no full year FY20 dividend paid 25 22.1 • Headroom in
Slide 18: Earnings Per Share
Earnings Per Share Cps 10 Earnings Per Share 9 • EPS at 6.18 cps (6.29 cps before the 8 application of IFRS 16) 7 6.25 6 5.69 6.18 5 4.89 4 3 2 1 0 1H18 1H19 1H20 1H21 IFRS 16 adjustment GXH Half Year Results Presentation 25 November 2020 Pg 18
Slide 19: Disclaimer
Disclaimer The information in this presentation was prepared by Green Cross Health Limited (GXH) with due care and attention. However, the information is supplied in summary form and is therefore not necessarily complete, and no representation is made as to the accuracy, completeness or reliability